Moreover, the authors showed that ERK1/2 are highly expressed in the matched colonic mucosa of the CRC patients; inhibiting these molecules may conceivably disrupt colonic homeostasis, which is thus not ideal. Here, MAPK3 is linked to colorectal carcinoma.